Mavens Consulting

Winner: 2014 Salesforce.com Partner Innovation Award for Marketing

Learn More 

Mavens Consulting Wins Marketing Partner Innovation Award at Dreamforce 2014

Mavens Consulting recognized for outstanding contribution toward customer success in third annual salesforce.com Partner Innovation Awards

San Francisco – Dreamforce 2014 – Oct. 13, 2014 – Mavens Consulting today announced it has been named the recipient of the salesforce.com Partner Innovation Award for Marketing Innovation. In receiving this award, Mavens Consulting is recognized for its work with Eli Lilly & Company, a top 10 global pharmaceutical company. Salesforce is transforming the way Lilly connects with Health Care Professionals (HCPs). The award was presented at Dreamforce 2014, the world’s largest software event.

Working with Mavens Consulting, Lilly is transforming their engagement with HCP customers in a rapidly shifting regulatory market. This change in the landscape demands a new level of engagement with customers to ensure compliance in a manner that maintains, and even enhances the relationship between Lilly and its customers. The solution integrates previously separate business processes in both CRM and legacy landscapes, providing a path to compliance, while putting the customer and their experience at the center to ensure this mandated change reflects positively on their relationship with Lilly. The solution supports and enables the underlying business processes providing Lilly with the necessary inputs for transparency reporting, and HCPs with a new community to engage Lilly as a meeting delegate or speaker.

Connecting with Customers, Partners and Employees to Thrive in Today’s Connected World

The Salesforce1 Platform is the next generation social, mobile and cloud platform for this connected world to transform sales, service, marketing, engagement and more. The Lilly solution built by Mavens on the Salesforce1 Platform improves customer experience by enabling comprehensive engagement with a shared global services center, incorporating the Service Cloud and Marketing Cloud to deliver localized and tailored communication across digital channels, including a mobile-enabled customer portal hosted on the Salesforce1 Platform.

Comments on the News

“Lilly is one of Mavens’ most innovative and forward-thinking clients. It is a thought leader in the pharmaceutical industry and its commitment to the Salesforce1 Platform is enabling it to engage customers in new and exciting ways,” said Joseph Ferraro, Chief Technology Officer, Mavens Consulting

“Mavens partnered with our team to evaluate our existing IT infrastructure, and proved that this solution could be built and deployed in the cloud. Our team has been impressed with how quickly we deployed and our ability to scale globally.” – Rich Grogut, IT Director, Cirrus & Global Commercial Operations, Eli Lilly & Company

“Mavens Consulting is a key partner for Salesforce in the Life Sciences industry. The Mavens team brings a depth of industry experience and expertise to every customer engagement and we are very excited about the innovative solutions they are building with Salesforce for customers like Eli Lilly & Company,” said Dan Streetman, Senior Vice President, Alliances and Channels, salesforce.com

Additional Resources

Become a fan of Mavens Consulting: http://www.facebook.com/MavensConsulting

Follow @mavens on Twitter: https://twitter.com/mavens

Salesforce, Salesforce1, AppExchange and others are among the trademarks of salesforce.com, inc.

About Mavens Consulting

Mavens Consulting is the life sciences industry’s premier salesforce.com implementation partner focused exclusively on crafting Salesforce and Veeva solutions for pharma, medical device companies, and payers. Mavens brings an in-depth knowledge of the entire Veeva product suite, deep technical expertise with the Salesforce1 platform, and unparalleled global industry experience that results in practical, tailored solutions delivering value. Founded in 2007, Mavens is headquartered in Chicago with offices throughout the U.S. and Europe.